SC TO-I
EX-FILING FEES
0001788028
0-11
N/A
0001788028
1
2026-10-07
2026-10-07
0001788028
2026-10-07
2026-10-07
iso4217:USD
xbrli:pure
xbrli:shares
Ex-Filing Fees
CALCULATION OF FILING FEE TABLES
SC TO
Jasper Therapeutics, Inc.
Table 1 to Paragraph (a)(7)
| |
|
|
|
|
|
|
|
|
|
|
| Line Item Type |
|
Notes |
|
Transaction
Valuation |
|
Fee Rate |
|
Amount
of
Filing Fee |
| |
|
|
|
|
|
|
|
|
|
|
| Fees to be Paid |
|
(1) |
|
$ |
4,000,009.07 |
|
0.0000870 |
|
$ |
348.00 |
| |
|
|
|
|
|
|
| Total Transaction Valuation: |
|
$ |
4,000,009.07 |
|
|
|
|
|
| Total Fees Due for Filing: |
|
|
|
|
|
|
$ |
348.00 |
| Total Fees Previously Paid: |
|
|
|
|
|
|
|
0.00 |
| Total Fee Offsets: |
|
|
|
|
|
|
|
0.00 |
| Net Fee Due: |
|
|
|
|
|
|
$ |
348.00 |
__________________________________________
Offering Note(s)
| (1) | |
The transaction valuation is estimated for purposes of calculating the amount of the filing fee only. The amount is based upon the offer to purchase up to 12,345,707 warrants for a purchase price of $0.324 per Warrant, for a transaction valuation of $4,000,009.07. The amount assumes all Warrants will be tendered pursuant to the Offer. |